Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Chemical Society Reviews|March 11, 2011
Recent developments in natural product synthesis using metal-catalysed C-H bond functionalisationLindsay McMurray, Fionn O'Hara, Matthew J Gaunt
Bioorganic & Medicinal Chemistry Letters|February 19, 2022
A unified "top-down" approach for the synthesis of diverse lead-like molecular scaffoldsChloe Townley, Lindsay McMurray, Stephen P Marsden, et al.
Journal of the American Chemical Society|June 21, 2012
Copper-catalyzed alkene arylation with diaryliodonium saltsRobert J Phipps, Lindsay McMurray, Stefanie Ritter, et al.
Molecular Pharmaceutics|May 9, 2022
Identification and Strategies to Mitigate High Total Clearance of Benzylamine-Substituted Biphenyl Ring SystemsBeth Williamson, Lindsay McMurray, Scott Boyd, et al.
Chemmedchem|December 13, 2017
[Carboxyl-11 C]Labelling of Four High-Affinity cPLA2α Inhibitors and Their Evaluation as Radioligands in Mice by Positron Emission TomographyMartin J Fisher, Lindsay McMurray, Shuiyu Lu, et al.
Chemmedchem|March 23, 2019
Radiosynthesis of (R,S)-[18 F]GE387: A Potential PET Radiotracer for Imaging Translocator Protein 18 kDa (TSPO) with Low Binding Sensitivity to the Human Gene Polymorphism rs6971Luxi Qiao, Emily Fisher, Lindsay McMurray, et al.
Archives of Toxicology|January 1, 2022
Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessmentGregory Hamm, Gareth Maglennon, Beth Williamson, et al.
ACS Chemical Neuroscience|March 10, 2021
Synthesis and Assessment of Novel Probes for Imaging Tau Pathology in Transgenic Mouse and Rat ModelsLindsay McMurray, Jennifer A Macdonald, Nisha Kuzhuppilly Ramakrishnan, et al.
Journal of Medicinal Chemistry|March 8, 2021
Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation StrategyJ Willem M Nissink, Sana Bazzaz, Carolyn Blackett, et al.
Journal of Medicinal Chemistry|September 3, 2021
Optimization of an Imidazo[1,2-a]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with In Vivo EfficacyWilliam McCoull, Scott Boyd, Martin R Brown, et al.
Pageof 2